Browse > Article
http://dx.doi.org/10.4110/in.2012.12.4.129

Immune Disorders and Its Correlation with Gut Microbiome  

Hwang, Ji-Sun (School of Life Sciences and Immune Synapse Research Center, Gwangju Institute of Science and Technology (GIST))
Im, Chang-Rok (Global Leader Program, Bugil Academy)
Im, Sin-Hyeog (School of Life Sciences and Immune Synapse Research Center, Gwangju Institute of Science and Technology (GIST))
Publication Information
IMMUNE NETWORK / v.12, no.4, 2012 , pp. 129-138 More about this Journal
Abstract
Allergic disorders such as atopic dermatitis and asthma are common hyper-immune disorders in industrialized countries. Along with genetic association, environmental factors and gut microbiota have been suggested as major triggering factors for the development of atopic dermatitis. Numerous studies support the association of hygiene hypothesis in allergic immune disorders that a lack of early childhood exposure to diverse microorganism increases susceptibility to allergic diseases. Among the symbiotic microorganisms (e.g. gut flora or probiotics), probiotics confer health benefits through multiple action mechanisms including modification of immune response in gut associated lymphoid tissue (GALT). Although many human clinical trials and mouse studies demonstrated the beneficial effects of probiotics in diverse immune disorders, this effect is strain specific and needs to apply specific probiotics for specific allergic diseases. Herein, we briefly review the diverse functions and regulation mechanisms of probiotics in diverse disorders.
Keywords
Hygiene hypothesis; Intestinal microflora; Gut-Associated lymphoid tissue; Probiotics; Atopic dermatitis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Feleszko, W., J. Jaworska, R. D. Rha, S. Steinhausen, A. Avagyan, A. Jaudszus, B. Ahrens, D. A. Groneberg, U. Wahn, and E. Hamelmann. 2007. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy 37:498-505.   DOI   ScienceOn
2 Leung, D. Y., M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657.   DOI
3 Leung, D. Y., N. Jain, and H. L. Leo. 2003. New concepts in the pathogenesis of atopic dermatitis. Curr. Opin. Immunol.15: 634-638.   DOI   ScienceOn
4 Okada, H., C. Kuhn, H. Feillet, and J. F. Bach. 2010. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin. Exp. Immunol. 160: 1-9.
5 Atherton, D. J. 2003. Topical corticosteroids in atopic dermatitis. BMJ 327: 942-943.   DOI   ScienceOn
6 Jia, W., H. Li, L. Zhao, and J. K. Nicholson. 2008. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 7: 123-129.   DOI   ScienceOn
7 Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:911-920.   DOI   ScienceOn
8 Maggi, E. 1998. The TH1/TH2 paradigm in allergy. Immunotechnology 3: 233-244.   DOI   ScienceOn
9 Rautava, S., O. Ruuskanen, A. Ouwehand, S. Salminen, and E. Isolauri. 2004. The hygiene hypothesis of atopic disease-- an extended version. J. Pediatr. Gastroenterol. Nutr. 38:378-388.   DOI   ScienceOn
10 Shreiner, A., G. B. Huffnagle, and M. C. Noverr. 2008. The "Microflora Hypothesis" of Allergic Disease. In GI Microbiota and Regulation of the Immune System. Springer, New York, USA. pp.113-134
11 Turnbaugh, P. J., R. E. Ley, M. Hamady, C. M. Fraser-Liggett, R. Knight, and J. I. Gordon. 2007. The human microbiome project. Nature 449: 804-810.   DOI   ScienceOn
12 Sheil, B., J. McCarthy, L. O'Mahony, M. W. Bennett, P. Ryan, J. J. Fitzgibbon, B. Kiely, J. K. Collins, and F. Shanahan. 2004. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53: 694-700.   DOI   ScienceOn
13 Madsen, K. L., J. S. Doyle, L. D. Jewell, M. M. Tavernini, and R. N. Fedorak. 1999. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116: 1107-1114.   DOI   ScienceOn
14 Schultz, M., C. Veltkamp, L. A. Dieleman, W. B. Grenther, P. B. Wyrick, S. L. Tonkonogy, and R. B. Sartor. 2002. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 8: 71-80.   DOI   ScienceOn
15 Khoruts, A., and M. J. Sadowsky. 2011. Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol. 4: 4-7.   DOI   ScienceOn
16 Delzenne, N. M., A. M. Neyrinck, F. Bäckhed, and P. D. Cani. 2011. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 7: 639-646.   DOI   ScienceOn
17 Favier, C., C. Neut, C. Mizon, A. Cortot, J. F. Colombel, and J. Mizon. 1997. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig. Dis. Sci.42: 817-822.   DOI   ScienceOn
18 Won, T. J., B. Kim, Y. T. Lim, D. S. Song, S. Y. Park, E. S. Park, D. I. Lee, and K. W. Hwang. 2011. Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC/Nga mice. J. Appl. Microbiol. 110: 1195-1202.   DOI   ScienceOn
19 Bouma, G., and W. Strober. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533.   DOI   ScienceOn
20 Swidsinski, A., A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, J. Weber, U. Hoffmann, S. Schreiber, M. Dietel, and H. Lochs. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.   DOI   ScienceOn
21 Gupta, P., H. Andrew, B. S. Kirschner, and S. Guandalini. 2000. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr. 31: 453-457.   DOI   ScienceOn
22 Kruis, W., P. Fric, and M. S. Stolte. 2001. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine. Gastroenterology 120(5 Suppl 1): A127.   DOI
23 Malchow, H. A. 1997. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J. Clin. Gastroenterol. 25: 653-658.   DOI   ScienceOn
24 Gionchetti, P., F. Rizzello, A. Venturi, P. Brigidi, D. Matteuzzi, G. Bazzocchi, G. Poggioli, M. Miglioli, and M. Campieri. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo- controlled trial. Gastroenterology 119: 305-309.   DOI   ScienceOn
25 Venturi, A., P. Gionchetti, F. Rizzello, R. Johansson, E. Zucconi, P. Brigidi, D. Matteuzzi, and M. Campieri. 1999. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther.13: 1103-1108.   DOI   ScienceOn
26 Kopp, M. V., I. Hennemuth, A. Heinzmann, and R. Urbanek. 2008. Randomized, double-blind, placebo-controlled trial of probiotics forprimary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121: e850-856.   DOI   ScienceOn
27 O'Mahony, L., M. Feeney, S. O'Halloran, L. Murphy, B. Kiely, J. Fitzgibbon, G. Lee, G. O'Sullivan, F. Shanahan, and J. K. Collins. 2001. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment. Pharmacol. Ther. 15: 1219-1225.   DOI   ScienceOn
28 Sheil, B., J. MacSharry, L. O'Callaghan, A. O'Riordan, A. Waters, J, Morgan, J. K. Collins, L. O'Mahony, and F. Shanahan. 2006. Role of interleukin (IL-10) in probioticmediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin. Exp. Immunol. 144: 273-280.   DOI   ScienceOn
29 Soh, S. E., M. Aw, I. Gerez, Y. S. Chong, M. Rauff, Y. P. Ng, H. B. Wong, N. Pai, B. W. Lee, and L. P. Shek. 2009. Probiotic supplementation in the first 6 months of life in at risk Asian infants--effects on eczema and atopic sensitization at the age of 1 year. Clin. Exp. Allergy 39: 571-578.   DOI   ScienceOn
30 Weston, S., A. Halbert, P. Richmond, and S. L. Prescott. 2005. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch. Dis. Child. 90: 892-897.   DOI   ScienceOn
31 Viljanen, M., E. Savilahti, T. Haahtela, K. Juntunen-Backman, R. Korpela, T. Poussa, T. Tuure, and M. Kuitunen. 2005. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60: 494-500.   DOI   ScienceOn
32 Sistek, D., R. Kelly, K. Wickens, T. Stanley, P. Fitzharris, and J. Crane. 2006. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin. Exp. Allergy36 :629-633.   DOI   ScienceOn
33 Fölster-Holst, R., F. Müller, N. Schnopp, D. Abeck, I. Kreiselmaier, T. Lenz, von U. Rüden, J. Schrezenmeir, E. Christophers, and M. Weichenthal. 2006. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br. J. Dermatol. 155: 1256-1261.   DOI   ScienceOn
34 Chen, Y. S., R. L. Jan, Y. L. Lin, H. H. Chen, and J. Y. Wang. 2010. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr. Pulmonol. 45: 1111-1120.   DOI   ScienceOn
35 Vestergaard, C., N. Kirstejn, B. Gesser, J. T. Mortensen, K. Matsushima, and C. G. Larsen. 2001. IL-10 augments the IFN-gamma and TNF-alpha induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis. J. Dermatol. Sci. 26: 46-54.   DOI   ScienceOn
36 Sawada, J., H. Morita, A. Tanaka, S. Salminen, F. He, and H. Matsuda. 2007. Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice. Clin. Exp. Allergy 37: 296-303.   DOI   ScienceOn
37 Tanaka, A., K. Jung, J. Benyacoub, G. Prioult, N. Okamoto, K. Ohmori, S. Blum, A. Mercenier, and H. Matsuda. 2009. Oral supplementation with Lactobacillus rhamnosus CGMCC1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-gamma. Exp. Dermatol. 18: 1022-1027.   DOI   ScienceOn
38 Homey, B., M. Steinhoff, T. Ruzicka, and D. Y. Leung. 2006. Cytokines and chemokines orchestrate atopic skin inflammation. J. Allergy Clin. Immunol. 118: 178-189.   DOI   ScienceOn
39 Konur, A., U. Schulz, G. Eissner, R. Andreesen, and E. Holler. 2005. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production. Br. J. Dermatol. 152: 1134-1142.   DOI   ScienceOn
40 Pivarcsi, A., and B. Homey. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr. Allergy Asthma Rep. 5: 284-290.
41 Trautmann, A., M. Akdis, D. Kleemann, F. Altznauer, H. U. Simon, T. Graeve, M. Noll, E. B. Bröcker, K. Blaser, and C. A. Akdis. 2000. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. 106: 25-35.   DOI   ScienceOn
42 Kalliomäki, M., S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 357: 1076-1079.   DOI   ScienceOn
43 Abrahamsson, T. R., T. Jakobsson, M. F. Bottcher, M. Fredrikson, M. C. Jenmalm, B. Bjorksten, and G. Oldaeus. 2007. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 119: 1174-1180.   DOI   ScienceOn
44 Kwon, H. K., C. G. Lee, J. S. So, C. S. Chae, J. S. Hwang, A. Sahoo, J. H. Nam, J. H. Rhee, K. C. Hwang, and S. H. Im. 2012. Generation of regulatory dendritic cells and $CD4^{+}Foxp3^{+}$ T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. U.S.A. 107: 2159-2164.
45 Wickens, K., P. N. Black, T. V. Stanley, E. Mitchell, P. Fitzharris, G. W. Tannock, G. Purdie, J. Crane Probiotic Study Group. 2008. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 122: 788-794.   DOI   ScienceOn
46 Smits, H. H., A. Engering, D. van der Kleij, E. C. de Jong, K. Schipper, T. M. van Capel, B. A. Zaat, M. Yazdanbakhsh, E. A. Wierenga, Y. van Kooyk, and M. L. Kapsenberg. 2005. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115: 1260-1267.   DOI   ScienceOn
47 Ueno, N., M. Fujiya, S. Segawa, T. Nata, K. Moriichi, H. Tanabe, Y. Mizukami, N. Kobayashi, K. Ito, and Y. Kohgo. 2011. Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. Inflamm. Bowel Dis. 17: 2235-2250.   DOI   ScienceOn
48 Winkler, P., D. Ghadimi, J. Schrezenmeir, and J. P. Kraehenbuhl. 2007. Molecular and cellular basis of microflora-host interactions. J. Nutr. 137(3 Suppl 2): 756S-772S.   DOI
49 Fink, L. N., L. H. Zeuthen, G. Ferlazzo, and H. Frøkiaer. 2007. Human antigen-presenting cells respond differently to gut-derived probiotic bacteria but mediate similar strain-dependent NK and T cell activation. FEMS Immunol. Med. Microbiol. 51: 535-546.   DOI
50 Young, S. L., M. A. Simon, M. A. Baird, G. W. Tannock, R. Bibiloni, K. Spencely, J. M. Lane, P. Fitzharris, J. Crane, I. Town, E. Addo-Yobo, C. S. Murray, and A. Woodcock. 2004. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin. Diagn. Lab. Immunol. 11: 686-690.
51 Zeuthen, L. H., H. R. Christensen, and H. Frøkiaer. 2006. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin. Vaccine Immunol. 13: 365-375.   DOI   ScienceOn
52 Lai, Y., A. Di Nardo, T. Nakatsuji, A. Leichtle, Y. Yang, A. L. Cogen, Z. R. Wu, L. V. Hooper, R. R. Schmidt, S. von Aulock, K. A. Radek, C. M. Huang, A. F. Ryan, and R. L. Gallo. 2009. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med. 15: 1377-1382.   DOI   ScienceOn
53 Grice, E. A., H. H. Kong, S. Conlan, C. B. Deming, J. Davis, A. C. Young NISC Comparative Sequencing Program, G. G. Bouffard, R. W. Blakesley, P. R. Murray, E. D. Green, M. L. Turner, and J. A. Segre. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324: 1190-1192.   DOI   ScienceOn
54 Gallo, R. L., and T. Nakatsuji. 2011. Microbial symbiosis with the innate immune defense system of the skin. J. Invest. Dermatol. 131: 1974-1980.   DOI   ScienceOn
55 Kong, H. H., J. Oh, C. Deming, S. Conlan, E. A. Grice, M. A. Beatson, E. Nomicos, E. C. Polley, H. D. Komarow, NISC Comparative Sequence Program, P. R. Murray, M. L. Turner, and J. A. Segre. 2012. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 22: 850-859.   DOI   ScienceOn
56 Naik, S., N. Bouladoux, C. Wilhelm, M. J. Molloy, R. Salcedo, W. Kastenmuller, C. Deming, M. Quinones, L. Koo, S. Conlan, S. Spencer, J. A. Hall, A. Dzutsev, H. Kong, D. J. Campbell, G. Trinchieri, J. A. Segre, and Y. Belkaid. 2012. Compartmentalized control of skin immunity by resident commensals. Science 337: 1115-1119.   DOI   ScienceOn
57 Ouwehand, A. C., M. Derrien, W. de Vos, K. Tiihonen, and N. Rautonen. 2005. Prebiotics and other microbial substrates for gut functionality. Curr. Opin. Biotechnol. 16: 212-217.   DOI   ScienceOn
58 Adlerberth, I., M. Cerquetti, I. Poilane, A. Wold, and A. Collignon. 2000. Mechanisms of Colonisation and Colonisation Resistance of the Digestive Tract Part 1: Bacteria/host Interactions. Microb. Ecol. Health Dis. 2: 223-239.
59 Fang, H., T. Elina, A. Heikki, and S. Seppo. 2000. Modulation of humoral immune response through probiotic intake. FEMS Immunol. Med. Microbiol. 29: 47-52.   DOI   ScienceOn
60 Gill, H. S., K. J. Rutherfurd, M. L. Cross, and P. K. Gopal. 2001. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 74: 833-839.   DOI
61 Giongo, A., K. A. Gano, D. B. Crabb, N. Mukherjee, L. L. Novelo, G. Casella, J. C. Drew, J. Ilonen, M. Knip, H. Hyöty, R. Veijola, T. Simell, O. Simell, J. Neu, C. H. Wasserfall, D. Schatz, M. A. Atkinson, and E. W. Triplett. 2011. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5:82-91.   DOI
62 Turnbaugh, P. J., R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.   DOI   ScienceOn
63 Ley, R. E., P. J. Turnbaugh, S. Klein, and J. I. Gordon. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.   DOI   ScienceOn
64 Million, M., M. Maraninchi, M. Henry, F. Armougom, H. Richet, P. Carrieri, R. Valero, D. Raccah, B. Vialettes, and D. Raoult. 2012. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int. J. Obes. (Lond). 36: 817-825.   DOI   ScienceOn
65 Ogden, N. S., and L. Bielory. 2005. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease. Curr. Opin. Allergy Clin. Immunol. 5: 179-184.   DOI   ScienceOn
66 Guarner, F., and J. R. Malagelada. 2003. Gut flora in health and disease. Lancet. 361: 512-519.   DOI
67 Artis, D. 2008. Epithelial-cell recognition ofcommensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8: 411-420.   DOI   ScienceOn
68 Macdonald, T. T., and G, Monteleone. 2005. Immunity, inflammation, and allergy in the gut. Science 307: 1920-1925.   DOI   ScienceOn
69 Kelly, D., S. Conway, and R. Aminov. 2005. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol. 26: 326-333.   DOI   ScienceOn
70 Coombes, J. L., and F. Powrie. 2008. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 8: 435-446.   DOI   ScienceOn
71 Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2: 361-367.   DOI   ScienceOn
72 Ostman, S., C. Rask, A. E. Wold, S. Hultkrantz, and E. Telemo. 2006. Impaired regulatory T cell function in germ-free mice. Eur. J. Immunol. 36: 2336-2346.   DOI   ScienceOn
73 Mowat, A. M. 2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3: 331-341.   DOI   ScienceOn
74 O'Hara, A. M., and F. Shanahan. 2006. The gut flora as a forgotten organ. EMBO Rep. 7: 688-693.   DOI   ScienceOn
75 Sudo, N., S. Sawamura, K. Tanaka, Y. Aiba, C. Kubo, and Y. Koga. 1997. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159: 1739-1745.
76 Kong, H. H. 2011. Skin microbiome: genomics-based insights into the diversity and role of skin microbes. Trends Mol. Med. 17: 320-328.   DOI   ScienceOn
77 Human Microbiome Jumpstart Reference Strains Consortium, K. E. Nelson, G. M. Weinstock, S. K. Highlander, K. C. Worley, H. H. Creasy, J. R. Wortman, D. B. Rusch, M. Mitreva, E. Sodergren, A. T. Chinwalla, M. Feldgarden, D. Gevers, B. J. Haas, R. Madupu, D. V. Ward, B. W. Birren, R. A. Gibbs, B. Methe, J. F. Petrosino, R. L. Strausberg, G. G. Sutton, O. R. White, R. K. Wilson, S. Durkin, M. G. Giglio, S. Gujja, C. Howarth, C. D. Kodira, N. Kyrpides, T. Mehta, D. M. Muzny, M. Pearson, K. Pepin, A. Pati, X. Qin, C. Yandava, Q. Zeng, L. Zhang, A. M. Berlin, L. Chen, T. A. Hepburn, J. Johnson, J. McCorrison, J. Miller, P. Minx, C. Nusbaum, C. Russ, S. M. Sykes, C. M. Tomlinson, S. Young, W. C. Warren, J. Badger, J. Crabtree, V. M. Markowitz, J. Orvis, A. Cree, S. Ferriera, L. L. Fulton, R. S. Fulton, M. Gillis, L. D. Hemphill, V. Joshi, C. Kovar, M. Torralba, K. A. Wetterstrand, A. Abouellleil, A. M. Wollam, C. J. Buhay, Y. Ding, S. Dugan, M. G. FitzGerald, M. Holder, J. Hostetler, S. W. Clifton, E. Allen-Vercoe, A. M. Earl, C. N. Farmer, K. Liolios, M. G. Surette, Q. Xu, C. Pohl, K. Wilczek-Boney, and D. Zhu. 2010. A catalog of reference genomes from the human microbiome. Science 328: 994-999.   DOI   ScienceOn
78 Tlaskalova-Hogenova, H., R. Stepankova, H. Kozakova, T. Hudcovic, L. Vannucci, L. Tuckova, P. Rossmann, T. Hrncir, M. Kverka, Z. Zakostelska, K. Klimesova, J. Pribylova, J. Bartova, D. Sanchez, P. Fundova, D. Borovska, D. Srutkova, Z. Zidek, M. Schwarzer, P. Drastich, and D. P. Funda. 2011. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell. Mol. Immunol. 8: 110-120.   DOI   ScienceOn
79 Cho, I., and M. J. Blaser. 2012. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13: 260-270.   DOI
80 Human Microbiome Project Consortium. 2012. A framework for human microbiome research. Nature 486: 215-221.   DOI   ScienceOn
81 Flohr, C., D. Pascoe, and H. C. Williams. 2005. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br. J. Dermatol. 152: 202-216.   DOI   ScienceOn
82 Gibbs, S., H. Surridge, R. Adamson, B. Cohen, G. Bentham, and R. Reading. 2004. Atopic dermatitis and the hygiene hypothesis: a case-control study. Int. J. Epidemiol. 33: 199-207.   DOI   ScienceOn
83 Kalliomaki, M., P. Kirjavainen, E. Eerola, P. Kero, S. Salminen, and E. Isolauri. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107: 129-134.   DOI   ScienceOn
84 Penders, J., C. Thijs, P. A. van den Brandt, I. Kummeling, B. Snijders, F. Stelma, H. Adams, R. van Ree, and E. E. Stobberingh. 2007. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56: 661-667.   DOI   ScienceOn
85 Kendler, M., W. Uter, A. Rueffer, R. Shimshoni, and E. Jecht. 2006. Comparison of fecal microflora in children with atopic eczema/dermatitis syndrome according to IgE sensitization to food. Pediatr. Allergy Immunol. 17: 141-147.   DOI   ScienceOn
86 Ouwehand, A. C. 2007. Antiallergic effects of probiotics. J. Nutr. 137(3 Suppl 2): 794S-797S.   DOI
87 Miraglia del Giudice, M. Jr., M. G. De Luca, and C. Capristo. 2002. Probiotics and atopic dermatitis. A new strategy in atopic dermatitis. Dig. Liver Dis. 34 Suppl 2: S68-71.   DOI
88 Sheil, B., F. Shanahan, and L. O'Mahony. 2007. Probiotic effects on inflammatory bowel disease. J. Nutr. 137(3 Suppl2): 819S-824S.   DOI
89 Sanders, M. E. 2008. Probiotics: definition, sources, selection, and uses. Clin. Infect. Dis. 46 Suppl 2: S58-61.   DOI